Plasma Branched-Chain Amino Acids Linked to Insulin Sensitivity

This article originally appeared here.
Share this content:
Plasma Branched-Chain Amino Acids Linked to Insulin Sensitivity
Plasma Branched-Chain Amino Acids Linked to Insulin Sensitivity

WEDNESDAY, Feb. 24, 2016 (HealthDay News) -- Plasma branched-chain amino acids (BCAAs) are associated with insulin sensitivity (SI) and metabolic clearance rate of insulin (MCRI), according to a study published online Feb. 19 in Diabetes Care.

C. Christine Lee, M.D., from the University of Toronto, and colleagues examined the correlations for BCAAs with SI, acute insulin response (AIR), and MCRI in 685 participants without diabetes from the Insulin Resistance Atherosclerosis Study. The authors measured plasma BCAAs (sum of valine, leucine, and isoleucine) by mass spectrometry, while frequently-sampled intravenous glucose tolerance tests were used to assess SI, AIR, and MCRI.

The researchers found that after adjustment for potential confounders, there was an inverse association for elevated plasma BCAAs with SI and MCRI, and a positive association for fasting insulin. Ethnicity significantly modified the correlation for BCAA with SI, with the correlation only significant in Caucasians and Hispanics. In Caucasians and Hispanics, but not African-Americans, elevated plasma BCAA correlated with incident diabetes (multivariable-adjusted odds ratio for one-standard deviation increase in plasma BCAAs, 1.67). There was no correlation for plasma BCAAs with SI-adjusted AIR.

"Plasma BCAAs are associated with incident diabetes and underlying metabolic abnormalities, although the associations were generally stronger in Caucasians and Hispanics," the authors write.

One author is employed by Metabolon, which provides metabolomics services and sells diagnostics for the management of metabolic disorders.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »